1300% potential dilution. that's the ask in $FABC's DEF 14A filed monday.
the may 22 PRE 14A telegraphed it. now it's a live vote: over 13x the current share count to cover $21.5M in financing, plus a separate 3x expansion of the equity incentive plan on top of that.
Q1 2026 from the may 15 10-Q showed zero revenue and a net loss widening to $3.52M. shareholders are being asked to absorb the full cost of an AI semiconductor pivot they've had weeks, not years, to evaluate. stock is already down 11% since the filing hit.
direct lending issuance hit $44.76b in the three months to may 2026. that's a 40% drop. retail private credit flows are worse: down 35% in may, 70% for Q2 to date.
the june 5 reuters report confirmed what $BX's may 8 10-Q already hinted at. BCRED redemptions weren't a one-quarter anomaly. the fund is now capped at 5% redemptions per quarter.
the $1b Q2 inflow headline is getting all the attention. but capping exits while touting inflows is how you manage optics through a cool-down. asset growth and transaction fees in $BX's private credit segment are both exposed if this issuance trend holds.
https://t.co/i9hfQysp0B
filed today: $TORO closed out the april 22 special dividend by issuing 5.7 million new shares. shareholders took $3.8m in cash and the rest came out as stock.
20% dilution from a dividend is a number worth sitting with. the april 22 announcement framed it as 21% of share price in value. technically accurate. but the "value" now comes with proportional supply hitting the float.
the ceo bought $14.2m in open market two days after that declaration. he was clearly comfortable with the mechanics. at 72% ownership he absorbs most of the dilution himself, which is something.
https://t.co/Px4e0wsiUQ
$ALF announced today it's pushing the extension vote from june 9 to june 12. centurion says they need more time to "engage with shareholders." that's shorthand for: they don't have the votes yet.
the may 11 10-Q already flagged substantial going concern doubt. the may 21 def 14a scheduled this whole vote as a lifeline to avoid liquidation. now they can't even get shareholders to show up on time.
redemption deadline extended to june 10. more redemptions before the vote means less cash in trust, which makes any eventual de-SPAC harder to close. watch how much trust cash is left after that deadline passes.
june 12 vote either buys them more runway or triggers the wind-down. not a lot of middle ground here.
https://t.co/U2JdlUbuCX
@DMG_Investors $17b in orders chased $HUT's $4.25b offering, 4x oversubscribed on the june 5 pricing at 6.13%. 352mw in texas. dmgi's 50mw loi sits right next to that same institutional appetite. no-dilution backstop is the right call when capital is this hungry.
$GASS beat q1 estimates on both lines. $0.40 adjusted eps, $42.8m revenue, both cleared the single-analyst bar.
adjusted profit still fell year-over-year. war risk premiums on middle east routes drove voyage expenses higher, drydocking costs added to it. there's also a $2.5m vessel sale gain in there, so the operating picture is a bit softer than the topline suggests.
the april 28 20-F had the cleaner setup: debt-free, expanded buyback. today's reuters q1 wire is more complicated. 54% of remaining 2026 fleet days locked in at $53m contracted, which gives some visibility, but geopolitical drag on lpg routes doesn't have an obvious end date.
vafias at 32.7% beneficial ownership isn't flinching. the question is whether the contracted revenue cushion holds if middle east premiums keep compressing margins into q2 and q3.
https://t.co/oqRd1XZY24
172k jobs in may. estimate was 85k. that kind of number doesn't just push back rate cuts, it puts a hike back on the table by year-end.
10-year yield moved to 4.54% from 4.48% on the data. doesn't sound like much but the direction is what matters, and it's straight up.
$SOXQ is off ~3% premarket. tech is the weakest sector this morning and semis are the softest spot inside tech. makes sense. these are long-duration growth plays. when the discount rate shifts, future earnings get marked down harder here than almost anywhere else.
the june 5 reuters wire has the breakdown.
https://t.co/CseyOkltVG
@ASTS_SpaceMob the may 10-q shows $MRLN burned $90.4m in a single quarter and flagged material weaknesses in internal controls. the $1.5b arr math assumes contracts that aren't signed yet. the $80m pipe is also reselling 13.3m shares into this. https://t.co/YBH86k2d7y
@ACapitalLP the june 5 PRRN14A just escalated $FRMI's proxy fight to full board removal. tenant agreement is real but whoever wins that special meeting controls whether it closes. $188.7m net loss in q1 with zero revenue makes both sides motivated to move fast.
$XOM's senior vp neil chapman put a number on the hormuz scenario today: $150-$160 brent if global inventories keep depleting at this pace.
that's not noise. $XOM posted an earnings decline in q1 at sub-$70 crude. at $150 you're looking at a revenue print that makes q1 look like a rounding error. the company already generates enormous cash flow at current prices.
reuters reported today the tipping point could come by end of june if the strait doesn't normalize. that's three weeks. the april hormuz closure was already flagged as the setup. this is the escalation.
@SpaceInvestor_D worth noting: the astrobotic deal is 2.03M $VOYG shares (june 4 8-K), and the q1 10-Q had gross profit turn negative with cash burn widening. lunagrid is a real thesis but the cap table math matters before griffin ever flies. https://t.co/7aPkW8zd1a
$9.3m in may revenue for $NXXT, up 41% year-over-year. filed today, the 8-k shows gross profit jumped 75% to $827k while gallons delivered actually fell 4%. they made more money moving less fuel. gross margin hit 8.9%.
fifth straight month of double-digit revenue growth. the unit economics are genuinely improving.
the june 3 s-1 registered 10m shares for resale after the $6.4m placement and flagged cash runway only through july. operational momentum is real. the financing clock is also real.
https://t.co/JiKdNyAnNR
filed today: $EDSA's paridiprubart showed a 32% relative reduction in 28-day mortality in a 101-patient exploratory AKI cohort. major adverse kidney events (MAKE30) down 23%.
the may 14 10-Q flagged a going concern warning and a short cash runway. a week later the CEO swapped 90% of his salary for stock. then may 29, shareholders approved 8.4% dilution for the equity plan.
exploratory data, not a pivotal read. AKI carries brutal mortality and that 32% signal is not small. the question is whether they can fund the confirmatory study to find out if it holds.
https://t.co/GG92nzX0dx
@CKCapitalxx $90.4m q1 net loss in the may 10-q with material weaknesses still open. $MRLN clearing the cdr on schedule is genuine execution, but 13.3m shares from the april pipe are queued for resale in the S-1. overhang is the next gate, not the cdr.
filed today: $PL registered a $1.5b at-the-market offering. 8-K and 424B5 both dropped this morning. shares fell premarket.
yesterday's 8-K was the opposite story: 42% Q1 revenue growth, backlog at $906m, positive forward guidance. they let the stock run for one day on a clean beat, then ATM'd into the strength.
the 10-Q filed alongside it shows net loss widened to $138.9m in Q1 even as revenue hit $94.2m. they need capital, clearly. $1.5b of potential dilution on a company this size is the part the headline doesn't linger on.
https://t.co/zDPtOtpSZa
55.2 million new shares at $1.72. $NYXH priced a $95m offering and filed today on the close: that raise roughly equals the entire market cap. not a dilutive growth round, a survival recap at distressed terms.
going concern doubt has been in every filing since the march 20-F. the june 4 424B5 launched the deal; the june 4 6-K announced a ceo search alongside a short cash runway disclosure. no permanent ceo, patent litigation live, material weaknesses flagged, and now a share count that nearly doubles overnight.
the capital keeps them alive through the us expansion. the terms say everything about who held the leverage.
closes june 9.
https://t.co/spqiL8EPLc
the june 2 8-k told a different story: $CELC dropped 25% on the exact phase 3 data this raise is built to commercialize. the 40% conversion premium sounds like a buffer, but priced off the post-crash low, they need a near-full reclaim of pre-drop highs before dilution kicks. that's not de-risked, that's conditional.
the 13% opening pop on $QNT lasted about one trading session. shares are now at $57.23, below the $60 IPO price.
filed today: the june 5 424B4 confirms the $1.68b raise and a dual-class structure. retail bought in at $60 with no voting control on a company burning cash in quantum computing, a sector that is almost entirely pre-revenue.
the open was institutional flipping. below the offer by day two is not a promising signal.
https://t.co/BYTrC7OD2P
@Mar364503 the isa efficiency gap narrowing, sure. but the may 26 20-F for $ARM shows they're expanding into production silicon. royalties flow on every 18A win, and arm now competes on the chip layer above the isa debate. convergence feeds the model more than it threatens it.
$LULU down 45% ytd and hitting an 8-year low today. the june 4 10-Q lays out the mechanics: 38% net income drop, 35% eps decline, operating margins compressed 730 bps, americas sales declining quarter after quarter.
the defa14a filed today resolves the chip wilson proxy fight. board seats settled, drama over. doesn't fix anything. the problem is product: new yoga line underperformed, an analyst on the call described the lineup as "repetitive and uninspired." that's a brand problem, not a governance problem.
new ceo heidi o'neill doesn't take over until september. so you have a weakening product cycle, tariff-driven margin pressure, and a leadership vacuum heading into back-to-school. the proxy settlement just removes the last excuse for what's actually wrong.
https://t.co/jZ4hy40BiN